NCT00957658

Accolade® TMZF® Hip Stem Outcomes Study

Accolade® TMZF® Study A Prospective, Post-market, Non-randomized, Multi-center Evaluation of the Accolade® TMZF® Hip Stem

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 241 (actual)
• Sponsor: Stryker Orthopaedics · Industry
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate clinical and radiographic outcome data in patients implanted with the Accolade® TMZF® femoral stem.

Detailed description

A prospective, post-market, multi-centered clinical evaluation of the Accolade® TMZF® hip stem device. All patients enrolled will receive the study device. All study patients will undergo a preoperative central Dual energy X-ray absorptiometry (DXA) scan to determine bone mineral density (BMD) values.

Conditions

• Arthroplasty, Replacement, Hip

Interventions

Type	Name	Description
DEVICE	Accolade® TMZF® Hip Stem	Accolade® TMZF® Hip Stem

Timeline

• Start date: 2006-03-01
• Primary completion: 2011-05-01
• Completion: 2014-05-01
• First posted: 2009-08-12
• Last updated: 2017-08-14
• Results posted: 2014-08-15

Locations

11 sites across 1 country: United States